Boeings LongTerm Trajectory Analyst Perspectives on the Next Decade LIC Increases Stake in Central Bank of India to 606 Silicon Valley Turns to Mundane Businesses AI and Dealmaking Reshape Accounting Property Management Alibaba Unveils Enhanced Zhenwu AI Chip and New Large Language Model China Emerges as Primary Rival in Humanoid Robot Race Musk Says Global Equity Funds Record First Weekly Outflow in Nine Weeks Amid Rising Inflation and Bond Yield Surge BOH Q1 2026 Earnings EPS Misses Estimates as Stock Slips CICB Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions RNAC Q1 2026 Earnings WiderthanExpected Loss Despite Positive Stock Reaction ATO Q1 2026 Earnings EPS Beat Amid Natural Gas Utility Strength TRS Q1 2026 Earnings EPS Surges Past Consensus Shares Gain 26 ARS Pharmaceuticals Inc SPRY Gains 4 as Shares Approach Key Resistance Level WD40 Company WDFC Posts Measured Gain as Shares Approach Key Resistance JLong Group Limited JL Sees Modest Gains Tests Key Resistance Zone RGA Stock Slides 09 as Reinsurance Sector Faces Headwinds Key Levels in Focus Rush Enterprises RUSHA Edges Lower as Resistance Holds at 7216 GE Vernova GEV Faces Headwinds Stock Dips 278 as Traders Eye Key Support Levels WilliamsSonoma Inc Gains Analyst Focus as Home Sector Faces Evolving Consumer Trends SNES Q1 2026 Earnings EPS Beat by 79 Highlights Expense Discipline Amid Revenue Opacity Genpacts Tyagarajan Warns AI May Reduce IT Workload and Curb Job Growth Valneva VALN Surges 48 as Vaccine Developer Tests Key Resistance Simmons First National Shows Modest Gains as Stock Holds Above Key Support IHS Holding Limited IHS Holds Steady Near Support as Telecom Infrastructure Stock Consolidates Evercore Inc EVR Climbs on Positive Trading Sentiment IB Acquisition Corp IBAC Slips Marginally as Stock Consolidates Near Support Dana Incorporated DAN Gains 169 as Shares Test Midrange Territory Iran Intensifies Claims Over Strait of Hormuz with New Map of Armed Forces Oversight CCEP Q4 2018 Earnings Slight EPS Miss as Bottler Reports Mixed Results Liminatus Pharma LIMN Holds Steady at 018 Key Levels Define NearTerm Range